SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-045823
Filing Date
2020-10-05
Accepted
2020-10-05 16:15:16
Documents
4
Period of Report
2020-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-8k_20201005.htm 8-K 40479
2 EX-10.1 nktx-ex101_7.htm EX-10.1 74983
3 EX-99.1 nktx-ex991_6.htm EX-99.1 13809
4 GRAPHIC gmehzm0rdllt000001.jpg GRAPHIC 13412
  Complete submission text file 0001564590-20-045823.txt   149194
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 650-215-0385
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 201223736
SIC: 2834 Pharmaceutical Preparations